Low Dose St John's Wort for Depression
NCT05477472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2022-07-28
Summary
This observational study observes the routine use of low-dose St John's Wort herbal mother tincture in patients with major depression. It measures intensity of depression at the beginning of St Johns Wort and after 6 weeks and evaluates tolerability and compliance.
Conditions
Interventions
- DRUG
-
St John's Wort
daily intake of CERES St John's Wort mother tincture. Dose according to the treating physician.
Sponsors & Collaborators
-
University of Zurich
collaborator OTHER -
Ceres Heilmittel AG
lead INDUSTRY
Principal Investigators
-
Natalie Kalbermatten, cand. med. · University of Zurich
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2007-01-31
- Completion
- 2007-01-31
Countries
- Switzerland
Study Locations
More Related Trials
-
St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
NCT00451516 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.
NCT02981225 ·Status: COMPLETED
-
Rhodiola Rosea Therapy of Major Depressive Disorder
NCT01098318 ·Status: COMPLETED ·Phase: PHASE3
-
Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
NCT00557427 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
NCT04532749 ·Status: TERMINATED ·Phase: PHASE3
-
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
NCT01607593 ·Status: COMPLETED
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250614 ·Status: COMPLETED ·Phase: PHASE3
-
Overuse of Antidepressant in Patients With Alzheimer Disease
NCT02529436 ·Status: COMPLETED
-
The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression
NCT01671124 ·Status: UNKNOWN
-
A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder
NCT04451187 ·Status: COMPLETED ·Phase: PHASE1
-
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00256113 ·Status: COMPLETED ·Phase: PHASE3
-
The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects
NCT01200615 ·Status: UNKNOWN ·Phase: NA
-
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
NCT04533529 ·Status: COMPLETED ·Phase: PHASE3
-
TC-5214 as add-on the Treatment of Major Depressive Disorder
NCT00692445 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)
NCT00997490 ·Status: TERMINATED ·Phase: PHASE3
-
Does Psilocybin Require Psychedelic Effects to Treat Depression?
NCT05710237 ·Status: COMPLETED ·Phase: PHASE2
-
The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder
NCT01418638 ·Status: UNKNOWN
-
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
NCT00118014 ·Status: COMPLETED ·Phase: PHASE4
-
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
NCT00250627 ·Status: COMPLETED ·Phase: PHASE3
-
Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression
NCT01099592 ·Status: TERMINATED ·Phase: PHASE4
-
Deprexil in Subjects With Signs and Symptoms of Depression
NCT01043367 ·Status: COMPLETED ·Phase: PHASE3
-
Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Glycopyrrolate (AIDES-G)
NCT01588717 ·Status: TERMINATED ·Phase: PHASE1
-
Interpersonal Psychotherapy for Severely Depressed Inpatients
NCT00325000 ·Status: TERMINATED ·Phase: NA
-
Pharmacotherapy in Depression With Panic Spectrum
NCT00177996 ·Status: COMPLETED ·Phase: PHASE4